A Senate committee recently approved Dr. Erica Schwartz’s nomination to be the next director of the United States’ top public health agency. This move followed concerns about her ability to resist political interference. If the full Senate confirms her, Schwartz would become the 22nd director of the Centers for Disease Control and Prevention (CDC), headquartered in Atlanta. The CDC’s primary role is to protect Americans from preventable health threats.
Schwartz’s professional background is extensive, holding both medical and law degrees. Her previous roles include deputy surgeon general and a leadership position in the U.S. Coast Guard. Her path to the nomination, however, was not without its challenges. During a Senate Health, Education, Labor, and Pensions Committee hearing, the topic of her standing up to political pressure emerged. Particularly, the discussion focused on whether she would challenge any directives from President Donald Trump’s health secretary, Robert F. Kennedy Jr., that lacked scientific support.
The committee’s chairman, Sen. Bill Cassidy of Louisiana, expressed initial doubts. Despite this, after further discussions with Schwartz and others, Cassidy shifted his stance, gaining confidence in her abilities. His support was crucial for the nomination’s progression.
The committee’s vote was almost entirely along party lines. Sen. Bernie Sanders of Vermont criticized the nomination. Sanders stressed the importance of having officials willing to confront anti-science sentiments within the administration. The CDC has faced internal instability, losing over 3,000 employees within a year. Morale has suffered due to constant leadership changes and appointments of individuals lacking medical or public health experience.
Public health experts were initially cautiously optimistic about Schwartz, pointing to her experience. Being a choice of Trump, not Kennedy, was another point in her favor. Kennedy, known for anti-vaccine views, had attempted to modify childhood vaccine guidelines, actions halted by a federal judge. Cassidy previously doubted Kennedy’s appointment as health secretary due to these perspectives. However, Kennedy’s assurances on maintaining current vaccine recommendations eventually gained Cassidy’s endorsement.
During Schwartz’s hearing, questions about her response to politically driven directives were prominent. While pledging to uphold scientific principles, her responses did not always convince public health groups. The National Public Health Coalition highlighted the need for firm commitments on maintaining scientific independence and evidence-based policies. Schwartz’s awareness of changes to CDC programs, including those promoting vaccinations, was also questioned.
Dr. Georges Benjamin, head of the American Public Health Association, noted Schwartz’s attempts to balance differing pressures. Despite disagreement on some responses, he supported her nomination. Benjamin emphasized the need for strong leadership at the CDC to restore its structure and public trust.
Dr. Daniel Jernigan, a former CDC official, echoed concerns that failing to confirm Schwartz would leave the agency without clear direction. He criticized Kennedy’s influence, suggesting that starting without a confirmed director suits his agenda.
Schwartz would be Trump’s third nominee for the role in 18 months, following Dr. David Weldon and Susan Monarez. Weldon’s hearing was canceled, citing insufficient senatorial support. Monarez, briefly confirmed, was removed for not aligning with the Trump administration’s objectives.
Additionally, the Senate committee forwarded another contentious nomination. Trump proposed Sean Kaufman for assistant health secretary for preparedness and response, a crucial role in public health emergency management. Kaufman faced criticism for vaccine-skeptic comments and his stance against mRNA technology projects. Despite these issues, Cassidy received assurances of improved oversight within the department and Kaufman’s limited role in vaccine policy.
Sanders voted against Kaufman, suggesting the public deserves better leadership choices. The Associated Press Health and Science Department reports this information with support from the Howard Hughes Medical Institute and the Robert Wood Johnson Foundation, holding responsibility for the content.